JPWO2020139978A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020139978A5 JPWO2020139978A5 JP2021537224A JP2021537224A JPWO2020139978A5 JP WO2020139978 A5 JPWO2020139978 A5 JP WO2020139978A5 JP 2021537224 A JP2021537224 A JP 2021537224A JP 2021537224 A JP2021537224 A JP 2021537224A JP WO2020139978 A5 JPWO2020139978 A5 JP WO2020139978A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- virus
- protein
- vlp
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000565 Capsid Proteins Proteins 0.000 claims 20
- 102100023321 Ceruloplasmin Human genes 0.000 claims 20
- 235000018102 proteins Nutrition 0.000 claims 19
- 102000004169 proteins and genes Human genes 0.000 claims 19
- 108090000623 proteins and genes Proteins 0.000 claims 19
- 102000037865 fusion proteins Human genes 0.000 claims 12
- 108020001507 fusion proteins Proteins 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 238000003776 cleavage reaction Methods 0.000 claims 9
- 108091005804 Peptidases Proteins 0.000 claims 7
- 239000004365 Protease Substances 0.000 claims 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 7
- 239000002245 particle Substances 0.000 claims 6
- 230000007017 scission Effects 0.000 claims 6
- 229960005486 vaccine Drugs 0.000 claims 6
- 206010025323 Lymphomas Diseases 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 241000701806 Human papillomavirus Species 0.000 claims 3
- 241000701822 Bovine papillomavirus Species 0.000 claims 2
- 206010014733 Endometrial cancer Diseases 0.000 claims 2
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 2
- 208000007514 Herpes zoster Diseases 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 241000701646 Kappapapillomavirus 2 Species 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- 102000005741 Metalloproteases Human genes 0.000 claims 2
- 108010006035 Metalloproteases Proteins 0.000 claims 2
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- 241001467552 Mycobacterium bovis BCG Species 0.000 claims 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
- 241001631646 Papillomaviridae Species 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 2
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 201000008968 osteosarcoma Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000005404 rubella Diseases 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 230000010415 tropism Effects 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 206010061424 Anal cancer Diseases 0.000 claims 1
- 208000007860 Anus Neoplasms Diseases 0.000 claims 1
- 208000032467 Aplastic anaemia Diseases 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 241000193738 Bacillus anthracis Species 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 241000588832 Bordetella pertussis Species 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000011691 Burkitt lymphomas Diseases 0.000 claims 1
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 claims 1
- 102000011727 Caspases Human genes 0.000 claims 1
- 108010076667 Caspases Proteins 0.000 claims 1
- 102000005600 Cathepsins Human genes 0.000 claims 1
- 108010084457 Cathepsins Proteins 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 241000606153 Chlamydia trachomatis Species 0.000 claims 1
- 241000193155 Clostridium botulinum Species 0.000 claims 1
- 241000193449 Clostridium tetani Species 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 241000724254 Cowpea chlorotic mottle virus Species 0.000 claims 1
- 241000723655 Cowpea mosaic virus Species 0.000 claims 1
- 241000699800 Cricetinae Species 0.000 claims 1
- 241000701022 Cytomegalovirus Species 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- 108700021041 Disintegrin Proteins 0.000 claims 1
- 241001115402 Ebolavirus Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000224432 Entamoeba histolytica Species 0.000 claims 1
- 241000709744 Enterobacterio phage MS2 Species 0.000 claims 1
- 241000991587 Enterovirus C Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241001534160 Escherichia virus Qbeta Species 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 claims 1
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 229920002971 Heparan sulfate Polymers 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 1
- 206010021042 Hypopharyngeal cancer Diseases 0.000 claims 1
- 206010056305 Hypopharyngeal neoplasm Diseases 0.000 claims 1
- 102000001399 Kallikrein Human genes 0.000 claims 1
- 108060005987 Kallikrein Proteins 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 206010023825 Laryngeal cancer Diseases 0.000 claims 1
- 241000589242 Legionella pneumophila Species 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
- 208000032271 Malignant tumor of penis Diseases 0.000 claims 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 1
- 201000005505 Measles Diseases 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 206010027480 Metastatic malignant melanoma Diseases 0.000 claims 1
- 208000003445 Mouth Neoplasms Diseases 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 241000714209 Norwalk virus Species 0.000 claims 1
- 208000010505 Nose Neoplasms Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 claims 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000002471 Penile Neoplasms Diseases 0.000 claims 1
- 206010034299 Penile cancer Diseases 0.000 claims 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 claims 1
- 241000224016 Plasmodium Species 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 102000016611 Proteoglycans Human genes 0.000 claims 1
- 108010067787 Proteoglycans Proteins 0.000 claims 1
- 241000125945 Protoparvovirus Species 0.000 claims 1
- 241000711798 Rabies lyssavirus Species 0.000 claims 1
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 201000000582 Retinoblastoma Diseases 0.000 claims 1
- 241000606701 Rickettsia Species 0.000 claims 1
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims 1
- 206010061934 Salivary gland cancer Diseases 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000701835 Salmonella virus P22 Species 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 102000012479 Serine Proteases Human genes 0.000 claims 1
- 108010022999 Serine Proteases Proteins 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000000728 Thymus Neoplasms Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 241000223997 Toxoplasma gondii Species 0.000 claims 1
- 241000589884 Treponema pallidum Species 0.000 claims 1
- 241000243774 Trichinella Species 0.000 claims 1
- 241000224526 Trichomonas Species 0.000 claims 1
- 241000223104 Trypanosoma Species 0.000 claims 1
- 208000037386 Typhoid Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 241000700618 Vaccinia virus Species 0.000 claims 1
- 241000700647 Variola virus Species 0.000 claims 1
- 241000607626 Vibrio cholerae Species 0.000 claims 1
- 206010047741 Vulval cancer Diseases 0.000 claims 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 claims 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- 208000008383 Wilms tumor Diseases 0.000 claims 1
- 241000710772 Yellow fever virus Species 0.000 claims 1
- 241000607734 Yersinia <bacteria> Species 0.000 claims 1
- 241000907316 Zika virus Species 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 201000011165 anus cancer Diseases 0.000 claims 1
- 229940065181 bacillus anthracis Drugs 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 201000000220 brain stem cancer Diseases 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 1
- 208000006990 cholangiocarcinoma Diseases 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000003431 cross linking reagent Substances 0.000 claims 1
- 206010013023 diphtheria Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000003914 endometrial carcinoma Diseases 0.000 claims 1
- 230000002357 endometrial effect Effects 0.000 claims 1
- 229940007078 entamoeba histolytica Drugs 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 208000024519 eye neoplasm Diseases 0.000 claims 1
- 201000003444 follicular lymphoma Diseases 0.000 claims 1
- 201000010175 gallbladder cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 229960002520 hepatitis vaccine Drugs 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 201000006866 hypopharynx cancer Diseases 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 206010023841 laryngeal neoplasm Diseases 0.000 claims 1
- 229940115932 legionella pneumophila Drugs 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000011649 lymphoblastic lymphoma Diseases 0.000 claims 1
- 208000006178 malignant mesothelioma Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims 1
- 208000021937 marginal zone lymphoma Diseases 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 208000037819 metastatic cancer Diseases 0.000 claims 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 claims 1
- 208000021039 metastatic melanoma Diseases 0.000 claims 1
- 208000010805 mumps infectious disease Diseases 0.000 claims 1
- 208000037830 nasal cancer Diseases 0.000 claims 1
- 201000008026 nephroblastoma Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000008106 ocular cancer Diseases 0.000 claims 1
- 201000006958 oropharynx cancer Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000003071 parasitic effect Effects 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 208000010916 pituitary tumor Diseases 0.000 claims 1
- 229940124733 pneumococcal vaccine Drugs 0.000 claims 1
- 206010038038 rectal cancer Diseases 0.000 claims 1
- 201000001275 rectum cancer Diseases 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 208000037968 sinus cancer Diseases 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 206010062113 splenic marginal zone lymphoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 210000002993 trophoblast Anatomy 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 201000008297 typhoid fever Diseases 0.000 claims 1
- 241001515965 unidentified phage Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
- 208000012991 uterine carcinoma Diseases 0.000 claims 1
- 201000003365 uterine corpus sarcoma Diseases 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 206010046885 vaginal cancer Diseases 0.000 claims 1
- 208000013139 vaginal neoplasm Diseases 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 201000005102 vulva cancer Diseases 0.000 claims 1
- 229940051021 yellow-fever virus Drugs 0.000 claims 1
Images
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024192929A JP2025023984A (ja) | 2018-12-27 | 2024-11-01 | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785502P | 2018-12-27 | 2018-12-27 | |
| US62/785,502 | 2018-12-27 | ||
| PCT/US2019/068619 WO2020139978A1 (en) | 2018-12-27 | 2019-12-26 | Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024192929A Division JP2025023984A (ja) | 2018-12-27 | 2024-11-01 | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022516088A JP2022516088A (ja) | 2022-02-24 |
| JPWO2020139978A5 true JPWO2020139978A5 (https=) | 2023-01-06 |
| JP2022516088A5 JP2022516088A5 (https=) | 2023-01-06 |
| JP7641005B2 JP7641005B2 (ja) | 2025-03-06 |
Family
ID=71129893
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537224A Active JP7641005B2 (ja) | 2018-12-27 | 2019-12-26 | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
| JP2024192929A Pending JP2025023984A (ja) | 2018-12-27 | 2024-11-01 | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024192929A Pending JP2025023984A (ja) | 2018-12-27 | 2024-11-01 | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11560408B2 (https=) |
| EP (1) | EP3902527A4 (https=) |
| JP (2) | JP7641005B2 (https=) |
| KR (1) | KR20210110321A (https=) |
| CN (1) | CN113396155A (https=) |
| AU (1) | AU2019414934A1 (https=) |
| CA (1) | CA3125184A1 (https=) |
| IL (1) | IL284410A (https=) |
| SG (1) | SG11202106931PA (https=) |
| WO (1) | WO2020139978A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| KR102797824B1 (ko) * | 2017-06-23 | 2025-04-17 | 버이뮨 아이엔씨. | 키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도 |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| SG11202106931PA (en) * | 2018-12-27 | 2021-07-29 | Verimmune Llc | Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| JP7657726B2 (ja) | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| WO2020252455A1 (en) | 2019-06-13 | 2020-12-17 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| EP4185600A4 (en) | 2020-07-24 | 2024-12-04 | The General Hospital Corporation | Enhanced virus-like particles and methods of use thereof for delivery to cells |
| IL302190A (en) * | 2020-10-19 | 2023-06-01 | Verimmune Inc | Virus-induced preparations and methods for redirecting immune responses in the use of said preparations for cancer treatment |
| US20250276056A1 (en) * | 2021-01-14 | 2025-09-04 | Raphael Paul Viscidi | Cytolytic t cell immunotherapy for highly pathogenic coronaviruses |
| US20240156937A1 (en) * | 2021-04-23 | 2024-05-16 | Unm Rainforest Innovations | Baceriophage virus-like particles vaccines for chlamydia trachomatis infections |
| CN118987197B (zh) * | 2024-10-24 | 2025-01-24 | 山东第二医科大学 | 一种自佐剂型热稳定纳米多价结核疫苗及其制备方法与应用 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164350A1 (en) | 1992-09-03 | 2002-11-07 | Lowy Douglas R. | Chimeric papillomavirus-like particles |
| US5618536A (en) | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
| US8062642B1 (en) | 1993-03-09 | 2011-11-22 | University Of Rochester | Production of papillomavirus capsid protein and virus-like particles |
| US20020039584A1 (en) | 1998-02-20 | 2002-04-04 | Medigene Ag | Papilloma virus capsomere vaccine formulations and methods of use |
| GB9806666D0 (en) | 1998-03-27 | 1998-05-27 | Stanley Margaret | Antigen preparation and use |
| EA004497B1 (ru) | 1998-12-04 | 2004-04-29 | Байоджен, Инк. | Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов |
| SE514982C2 (sv) | 1999-09-30 | 2001-05-28 | Active Biotech Ab | Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning |
| CN1114690C (zh) | 2001-05-15 | 2003-07-16 | 乔良 | 乳头瘤假病毒及其制备方法 |
| US9045727B2 (en) | 2002-05-17 | 2015-06-02 | Emory University | Virus-like particles, methods of preparation, and immunogenic compositions |
| GB2392158B (en) | 2002-08-21 | 2005-02-16 | Proimmune Ltd | Chimeric MHC protein and oligomer thereof |
| KR20050114225A (ko) | 2003-03-07 | 2005-12-05 | 머크 앤드 캄파니 인코포레이티드 | 인플루엔자 바이러스 백신 |
| AU2004238843B2 (en) * | 2003-05-09 | 2009-04-23 | Research Development Foundation | Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
| WO2006037787A2 (en) | 2004-10-05 | 2006-04-13 | Cytos Biotechnology Ag | Vlp-antigen conjugates and their uses as vaccines |
| KR20080015854A (ko) | 2005-06-14 | 2008-02-20 | 사이토스 바이오테크놀로지 아게 | 항원 컨쥬게이트 및 그의 용도 |
| US20070160628A1 (en) | 2005-08-31 | 2007-07-12 | Birkett Ashley J | Stabilized virus-like particles and epitope display systems |
| US20070104689A1 (en) * | 2005-09-27 | 2007-05-10 | Merck Patent Gmbh | Compositions and methods for treating tumors presenting survivin antigens |
| JP5564181B2 (ja) | 2005-12-08 | 2014-07-30 | シルワン，ハヴァル | 免疫刺激組成物および方法 |
| WO2008082719A2 (en) * | 2006-08-30 | 2008-07-10 | University Of Rochester | Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
| HUE030437T2 (en) | 2007-05-08 | 2017-05-29 | Us Health | Papillomavirus pseudoviruses for detection and therapy of tumors |
| US8088392B2 (en) | 2007-06-18 | 2012-01-03 | Yunxu Cao | Capsid proteins and uses therefore |
| US20100260792A1 (en) * | 2007-10-22 | 2010-10-14 | University Of Rochester | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| WO2009092113A2 (en) | 2008-01-19 | 2009-07-23 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for the delivery of vaccines to disrupted epithelium |
| EP2288380B1 (en) | 2008-06-09 | 2020-06-03 | Bharat Biotech International Limited | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same |
| WO2010118424A2 (en) | 2009-04-10 | 2010-10-14 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| EP3427755B1 (en) | 2009-04-13 | 2020-10-21 | INSERM - Institut National de la Santé et de la Recherche Médicale | Hpv particles and uses thereof |
| AU2010243285B2 (en) * | 2009-04-30 | 2013-06-06 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
| CN102869384B (zh) * | 2009-06-22 | 2016-01-13 | 伯纳姆医学研究所 | 使用带有c-端元件的肽和蛋白质的方法和组合物 |
| WO2012033911A2 (en) | 2010-09-08 | 2012-03-15 | The Johns Hopkins University | Polyionic papilloma virus-like particle (vlp) vaccines |
| CN102153656B (zh) | 2011-01-12 | 2014-11-19 | 广州市元通医药科技有限公司 | 一种嵌合病毒样颗粒疫苗及其制备方法 |
| JP6130307B2 (ja) | 2011-03-17 | 2017-05-17 | ザ ユニバーシティ オブ バーミンガム | 再指向性免疫療法 |
| WO2012141984A1 (en) * | 2011-04-08 | 2012-10-18 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
| JP2014521687A (ja) | 2011-07-29 | 2014-08-28 | セレクタ バイオサイエンシーズ インコーポレーテッド | 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア |
| SG11201401579UA (en) | 2011-12-01 | 2014-07-30 | Univ Cape Town | Hpv chimaeric particle |
| WO2013119877A1 (en) | 2012-02-07 | 2013-08-15 | Aura Biosciences, Inc. | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| US9561275B2 (en) | 2012-09-14 | 2017-02-07 | The Johns Hopkins University | Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing |
| US20160206715A1 (en) | 2013-03-15 | 2016-07-21 | Bullet Biotechnology, Inc. | Specific multivalent virus-like particle vaccines and uses thereof |
| MX385842B (es) | 2013-09-18 | 2025-03-18 | Aura Biosciences Inc | Conjugados de partículas de tipo virus y uso de las mismas. |
| CA2939093A1 (en) * | 2014-02-14 | 2015-08-20 | Immune Design Corp. | Immunotherapy of cancer through combination of local and systemic immune stimulation |
| US10413603B2 (en) | 2014-06-19 | 2019-09-17 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for improved human papilloma virus constructs |
| CA2967336C (en) * | 2014-11-07 | 2023-09-26 | Case Western Reserve University | Cancer immunotherapy using virus particles |
| WO2016112921A1 (en) | 2015-01-15 | 2016-07-21 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| EP3258969B1 (en) | 2015-02-18 | 2019-03-20 | F. Hoffmann-La Roche AG | Immunoconjugates for specific induction of t cell cytotoxicity against a target cell |
| WO2016176164A1 (en) | 2015-04-28 | 2016-11-03 | Albert Einstein College Of Medicine, Inc. | Treatment of cancer using recall antigens delivered by attenuated bacteria |
| WO2017020570A1 (en) | 2015-08-06 | 2017-02-09 | Medigen Biotechnology Corp. | Virus-like particle vaccines |
| CA2996762A1 (en) * | 2015-08-31 | 2017-03-09 | Technovax, Inc. | Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine |
| WO2017075615A1 (en) | 2015-10-29 | 2017-05-04 | Bullet Biotechnology, Inc. | Virus-like particle intermediates, agents attached thereto, methods for making and uses thereof |
| US20180311374A1 (en) * | 2015-10-30 | 2018-11-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv | Targeted cancer therapy |
| ES2854726T3 (es) | 2015-10-30 | 2021-09-22 | The Univ Of Copenhagen | Partícula similar a virus con presentación eficiente de epítopos |
| WO2017075440A1 (en) | 2015-10-30 | 2017-05-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Targeted cancer therapy |
| US10722537B2 (en) | 2015-11-06 | 2020-07-28 | Regents Of The University Of Minnesota | Activation of resident memory T cells for cancer immunotherapy |
| ES2873846T5 (en) | 2015-11-19 | 2025-06-23 | Revitope Ltd | Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells |
| WO2017112830A1 (en) | 2015-12-21 | 2017-06-29 | La Jolla Institute For Allergy And Immunology | Leveraging immune memory from common childhood vaccines to fight disease |
| US11351237B2 (en) | 2015-12-22 | 2022-06-07 | Thomas Jefferson University | CMV-based intra-tumoral cancer therapies |
| WO2017177204A1 (en) | 2016-04-09 | 2017-10-12 | La Jolla Institute For Allergy And Immunology | Leveraging immune memory from common childhood vaccines to fight disease |
| US20200078401A1 (en) * | 2016-12-07 | 2020-03-12 | La Jolla Institute For Allergy And Immunology | Compositions for cancer treatment and methods and uses for cancer treatment and prognosis |
| US11197890B2 (en) * | 2016-12-12 | 2021-12-14 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines |
| KR102797824B1 (ko) * | 2017-06-23 | 2025-04-17 | 버이뮨 아이엔씨. | 키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도 |
| EP3661550A4 (en) | 2017-08-03 | 2021-08-04 | Regents of the University of Minnesota | ACTIVATION OF LYMPHOCYTES T MEMORY RESIDENTS FOR THE TREATMENT OF CANCER |
| EP3706783A1 (en) | 2017-11-06 | 2020-09-16 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Cancer treatment utilizing pre-existing microbial immunity |
| EP3823668A1 (en) | 2018-07-16 | 2021-05-26 | DCPrime B.V. | A combination product for use in tumor vaccination |
| SG11202106931PA (en) * | 2018-12-27 | 2021-07-29 | Verimmune Llc | Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors |
| KR20210151848A (ko) | 2019-03-26 | 2021-12-14 | 아우라 바이오사시언시스, 인크. | 인간 파필로마바이러스 나노입자 제제 |
-
2019
- 2019-12-26 SG SG11202106931PA patent/SG11202106931PA/en unknown
- 2019-12-26 WO PCT/US2019/068619 patent/WO2020139978A1/en not_active Ceased
- 2019-12-26 CA CA3125184A patent/CA3125184A1/en active Pending
- 2019-12-26 KR KR1020217022435A patent/KR20210110321A/ko active Pending
- 2019-12-26 CN CN201980089773.2A patent/CN113396155A/zh active Pending
- 2019-12-26 EP EP19903832.4A patent/EP3902527A4/en active Pending
- 2019-12-26 JP JP2021537224A patent/JP7641005B2/ja active Active
- 2019-12-26 AU AU2019414934A patent/AU2019414934A1/en active Pending
- 2019-12-26 US US16/727,781 patent/US11560408B2/en active Active
-
2021
- 2021-06-27 IL IL284410A patent/IL284410A/en unknown
-
2022
- 2022-08-15 US US17/888,252 patent/US12528839B2/en active Active
-
2024
- 2024-11-01 JP JP2024192929A patent/JP2025023984A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020139978A5 (https=) | ||
| JP7641005B2 (ja) | コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用 | |
| JP5794747B2 (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
| JP2007512842A5 (https=) | ||
| JP2020524710A5 (https=) | ||
| EP2425848A3 (en) | Influenza immunogen and vaccine | |
| JP2022166109A (ja) | アデノウイルスコートタンパク質由来送達賦形剤 | |
| JP2012501347A5 (https=) | ||
| JP2009501001A5 (https=) | ||
| JPS59500498A (ja) | １ａ型乳頭腫ウイルスゲノムのＬ１及びＬ２領域由来のＤＮＡ断片 | |
| JP2009516529A5 (https=) | ||
| JP2012511322A5 (https=) | ||
| Lei et al. | Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines | |
| WO2003068163A3 (en) | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells | |
| JP2023501979A (ja) | 改変カプシドタンパク質を備えるウイルス | |
| CN102112152A (zh) | 适用于hpv和乙型肝炎感染的疫苗组合物以及其制备方法 | |
| JP2011530524A5 (https=) | ||
| WO2009055491A3 (en) | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres | |
| CN110891602A (zh) | 嵌合病毒样颗粒以及其作为免疫反应的抗原特异性重定向剂的用途 | |
| JP2010508857A5 (https=) | ||
| WO2009014782A3 (en) | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles | |
| Sazegari et al. | Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice | |
| JP2003514576A5 (https=) | ||
| JP2010538619A5 (https=) | ||
| ES2275350T3 (es) | Sistema de administracion de proteinas usando particulas de tipo virus de papilomavirus humano. |